Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1953 2
1956 3
1957 1
1961 2
1962 6
1963 4
1964 2
1965 2
1966 1
1967 1
1968 1
1969 7
1970 1
1971 1
1972 7
1973 9
1974 4
1975 10
1976 13
1977 8
1978 5
1979 12
1980 10
1981 13
1982 4
1983 13
1984 8
1985 11
1986 15
1987 26
1988 31
1989 36
1990 26
1991 28
1992 32
1993 38
1994 46
1995 62
1996 59
1997 71
1998 70
1999 87
2000 91
2001 140
2002 119
2003 180
2004 167
2005 276
2006 274
2007 300
2008 367
2009 409
2010 512
2011 517
2012 526
2013 549
2014 547
2015 519
2016 615
2017 601
2018 594
2019 593
2020 736
2021 777
2022 744
2023 585
2024 204

Text availability

Article attribute

Article type

Publication date

Search Results

10,493 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial.
Albiges L, Gurney H, Atduev V, Suarez C, Climent MA, Pook D, Tomczak P, Barthelemy P, Lee JL, Stus V, Ferguson T, Wiechno P, Gokmen E, Lacombe L, Gedye C, Perini RF, Sharma M, Peng X, Lee CH. Albiges L, et al. Among authors: lee ch. Lancet Oncol. 2023 Aug;24(8):881-891. doi: 10.1016/S1470-2045(23)00276-0. Epub 2023 Jul 11. Lancet Oncol. 2023. PMID: 37451291 Clinical Trial.
Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.
Tang C, Xie AX, Liu EM, Kuo F, Kim M, DiNatale RG, Golkaram M, Chen YB, Gupta S, Motzer RJ, Russo P, Coleman J, Carlo MI, Voss MH, Kotecha RR, Lee CH, Tansey W, Schultz N, Hakimi AA, Reznik E. Tang C, et al. Among authors: lee ch. Cell Metab. 2023 Aug 8;35(8):1424-1440.e5. doi: 10.1016/j.cmet.2023.06.005. Epub 2023 Jul 5. Cell Metab. 2023. PMID: 37413991 Free article.
Double trouble.
Lee CH, Scheinman MM. Lee CH, et al. Heart Rhythm. 2023 Oct;20(10):1414-1415. doi: 10.1016/j.hrthm.2023.02.001. Heart Rhythm. 2023. PMID: 37777302 No abstract available.
Secreted Akkermansia muciniphila threonyl-tRNA synthetase functions to monitor and modulate immune homeostasis.
Kim SM, Park S, Hwang SH, Lee EY, Kim JH, Lee GS, Lee G, Chang DH, Lee JG, Hwang J, Lee Y, Kyung M, Kim EK, Kim JH, Kim TH, Moon JH, Kim BC, Ko G, Kim SY, Ryu JH, Lee JS, Lee CH, Kim JY, Kim S, Lee WJ, Kim MH. Kim SM, et al. Among authors: lee ch. Cell Host Microbe. 2023 Jun 14;31(6):1021-1037.e10. doi: 10.1016/j.chom.2023.05.007. Epub 2023 Jun 2. Cell Host Microbe. 2023. PMID: 37269833 Free article.
Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical Trial.
Kang DY, Ahn JM, Yun SC, Hur SH, Cho YK, Lee CH, Hong SJ, Lim S, Kim SW, Won H, Oh JH, Choe JC, Hong YJ, Yoon YH, Kim H, Choi Y, Lee J, Yoon YW, Kim SJ, Bae JH, Park DW, Park SJ; OCTIVUS Investigators. Kang DY, et al. Among authors: lee ch. Circulation. 2023 Oct 17;148(16):1195-1206. doi: 10.1161/CIRCULATIONAHA.123.066429. Epub 2023 Aug 27. Circulation. 2023. PMID: 37634092 Clinical Trial.
A swinging rhythm.
Lee CH, Scheinman MM. Lee CH, et al. Heart Rhythm. 2023 Dec;20(12):1789-1790. doi: 10.1016/j.hrthm.2023.08.021. Heart Rhythm. 2023. PMID: 38040482 No abstract available.
"Short" also matters.
Lee CH, Scheinman MM. Lee CH, et al. Heart Rhythm. 2023 Aug;20(8):1197-1198. doi: 10.1016/j.hrthm.2023.02.026. Heart Rhythm. 2023. PMID: 37517862 No abstract available.
10,493 results
You have reached the last available page of results. Please see the User Guide for more information.